Diagnosis, treatment and prevention of severe acute respiratory syndrome coronavirus 2 infection in children: experts’ consensus statement updated for the Omicron variant

World Health Organization. Weekly epidemiological update on COVID-19-4 January 2023.2023. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---4-january-2023. Accessed 12 Jan 2023.

Chinese Center for Disease Control and Prevention. A few things you need to know about the BQ.1. 2022. https://www.chinacdc.cn/yyrdgz/202212/t20221213_263008.html. Accessed 5 Jan 2023.

Ma XW. Report of the State Council on the promotion of Children′s health. 2022. http://www.npc.gov.cn/npc/c30834/202206/3442472183a94b29a3edd6a1cf978aa1.shtml. Accessed 6 Jan 2023.

National Health Commission of the People’s Republic of China. Diagnosis and treatment plan of SARS-CoV-2 Infection (Trial Version 10). 2023. http://www.nhc.gov.cn/ylyjs/pqt/202301/32de5b2ff9bf4eaa88e75bdf7223a65a/files/02ec13aadff048ffae227593a6363ee8.pdf. Accessed 6 Jan 2023.

Jiang RM, Xie ZD, Jiang Y, Lu XX, Jin RM, Zheng YJ, et al. Diagnosis, treatment and prevention of severe acute respiratory syndrome coronavirus 2 infection in children: experts’ consensus statement (fourth edition). Chin J Appl Clin Pediatr. 2022;37:1053–65 (In Chinese).

Google Scholar 

Desingu PA, Nagarajan K. Omicron BA.2 lineage spreads in clusters and is concentrated in Denmark. J Med Virol. 2022;94:2360–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

World Health Organization. WHO Director-General′s opening remarks at the WHO press conference-13 April 2022. 2022. https://www.who.int/director-general/speeches/detail/3. Accessed 5 Jan 2023.

UK Health Security Agency. COVID-19 variants identified in the UK – latest updates. 2022. https://www.gov.uk/government/news/covid-19-variants-identified-in-the-uk-latest-updates. Accessed 5 Jan 2023.

Global Virus Network. COVID-19 variants and vaccines. 2021. https://gvn.org/covid-19-variants-and-vaccines. Accessed 5 Jan 2023.

Wang Q, Guo Y, Iketani S, Nair MS, Li Z, Mohri H, et al. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. 2022;608:603–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aboubakr HA, Sharafeldin TA, Goyal SM. Stability of SARS-CoV-2 and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: a review. Transbound Emerg Dis. 2021;68:296–312.

Article  CAS  PubMed  Google Scholar 

Ren SY, Wang WB, Hao YG, Zhang HR, Wang ZC, Chen YL, et al. Stability and infectivity of coronaviruses in inanimate environments. World J Clin Cases. 2020;8:1391–9.

Article  PubMed  PubMed Central  Google Scholar 

van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382:1564–7.

Article  PubMed  Google Scholar 

Hirose R, Itoh Y, Ikegaya H, Miyazaki H, Watanabe N, Yoshida T, et al. Differences in environmental stability among SARS-CoV-2 variants of concern: both omicron BA.1 and BA.2 have higher stability. Clin Microbiol Infect. 2022;28:1486–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271-80.e8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G, et al. Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J Clin Med. 2020;9:1417.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ren X, Wen W, Fan X, Hou W, Su B, Cai P, et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell. 2021;184:1895-913.e19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu B, Chan JF, Liu H, Liu Y, Chai Y, Shi J, et al. Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2. Emerg Microbes Infect. 2022;11:2275–87.

Article  PubMed  PubMed Central  Google Scholar 

Meng B, Abdullahi A, Ferreira IATM, Goonawardane N, Saito A, Kimura I, et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022;603:706–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Machado-Curbelo C, Gutiérrez-Gil J, González-Quevedo A. A shift in SARS-CoV-2 Omicron variant’s entry pathway might explain different clinical outcomes. MEDICC Rev. 2022;24:68–71.

Article  PubMed  Google Scholar 

Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020;395:1517–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chi H, Chang L, Chao YC, Lin DS, Yang HW, Fang LC, et al. Pathogenesis and preventive tactics of immune-mediated non-pulmonary COVID-19 in children and beyond. Int J Mol Sci. 2022;23:14157.

Article  CAS  PubMed  PubMed Central  Google Scholar 

American Academy of Pediatrics. What is the case definition of multisystem inflammatory syndrome in children (MIS-C)?.2022. https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/multisystem-inflammatory-syndrome-in-children-mis-c-interim-guidance. Accessed 6 Jan 2023.

Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370:eabd4570.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, et al. Autoantibodies neutralizing type I IFNs are present in -4% of uninfected individuals over 70 years old and account for -20% of COVID-19 deaths. Sci Immunol. 2021;6:eabl4340.

Article  PubMed  PubMed Central  Google Scholar 

Deshmukh V, Motwani R, Kumar A, Kumari C, Raza K. Histopathological observations in COVID-19: a systematic review. J Clin Pathol. 2021;74:76–83.

Article  CAS  PubMed  Google Scholar 

Calabrese F, Pezzuto F, Fortarezza F, Hofman P, Kern I, Panizo A, et al. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European pulmonary pathologists. Virchows Arch. 2020;477:359–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782–93.

Article  CAS  PubMed  Google Scholar 

Menger J, Apostolidou S, Edler C, Kniep I, Kobbe R, Singer D, et al. Fatal outcome of SARS-CoV-2 infection (B1.1.7) in a 4-year-old child. Int J Legal Med. 2022;136:189–92.

Article  PubMed  Google Scholar 

Nomura E, Finn LS, Bauer A, Rozansky D, Iragorri S, Jenkins R, et al. Pathology findings in pediatric patients with COVID-19 and kidney dysfunction. Pediatr Nephrol. 2022;37:2375–81.

Article  PubMed  PubMed Central  Google Scholar 

Gomes I, Karmirian K, Oliveira JT, Pedrosa CDSG, Mendes MA, Rosman FC, et al. SARS-CoV-2 infection of the central nervous system in a 14-month-old child: a case report of a complete autopsy. Lancet Reg Health Am. 2021;2:100046.

PubMed  PubMed Central  Google Scholar 

Duarte-Neto AN, Caldini EG, Gomes-Gouvêa MS, Kanamura CT, de Almeida Monteiro RA, Ferranti JF, et al. An autopsy study of the spectrum of severe COVID-19 in children: from SARS to different phenotypes of MIS-C. EClinicalMedicine. 2021;35:100850.

Article  PubMed  PubMed Central  Google Scholar 

Goussard P, Schubert P, Parker N, Myburgh C, Rabie H, van der Zalm MM, et al. Fatal SARS-CoV-2 Omicron variant in a young infant: autopsy findings. Pediatr Pulmonol. 2022;57:1363–5.

Article  PubMed  PubMed Central  Google Scholar 

Ji TY, Jiang YW. Pay attention to the nervous system involvement in SARS-CoV-2 infection in children. Chin J Pediatr. 2023;61:100–3 (In Chinese).

CAS  Google Scholar 

Expert Group on Intensive Care for SARS-CoV-2 Infection, Beijing Children′s Hospital, Capital Medical University, National Center for Children′s Health, Beijing Municipal Expert Group on Medical Treatment of SARS-CoV-2 Infection for Children. Recommendations for early identification, diagnosis and treatment of severe SARS-CoV-2 infection in children. Chin J Pediatr. 2023;61:199–202 (In Chinese).

Google Scholar 

Liguoro I, Pilotto C, Bonanni M, Ferrari ME, Pusiol A, Nocerino A, et al. SARS-COV-2 infection in children and newborns: a systematic review. Eur J Pediatr. 2020;179:1029–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 3. Arthritis Rheumatol. 2022;74:e1-20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scohy A, Anantharajah A, Bodéus M, Kabamba-Mukadi B, Verroken A, Rodriguez-Villalobos H, et al. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J Clin Virol. 2020;129:104455.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chinese Society of Radiology, Chinese Medical Association. Radiological diagnosis of COVID-19:expert recommendation from the Chinese society of radiology (First edition). Chin J Radiol. 2020;54:279–85 (In Chinese).

Google Scholar 

Ma HJ, Shao JB, Wang YJ, Zai AG, Zheng NN, Li Q, et al. High resolution CT features of COVID-19 in children. Chin J Radiol. 2020;54:310–3 (In Chinese).

Google Scholar 

Ma H, Hu J, Tian J, Zhou X, Li H, Laws MT, et al. A single-center, retrospective study of COVID-19 features in children: a descriptive investigation. BMC Med. 2020;18:123.

Article  PubMed  PubMed Central  Google Scholar 

Peng X, Guo Y, Xiao H, Xia W, Zhai A, Zhu B, et al. Overview of chest involvement at computed tomography in children with coronavirus disease 2019 (COVID-19). Pediatr

留言 (0)

沒有登入
gif